SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-24-031308
Filing Date
2024-06-25
Accepted
2024-06-25 16:23:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 ny20030990x3_424b3.htm 424B3 345698
2 ny20030990logo.jpg GRAPHIC 34883
3 ny20030990logox1.jpg GRAPHIC 41540
  Complete submission text file 0001140361-24-031308.txt   451871
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280215 | Film No.: 241069262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)